KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit

Early in 2016, KHB's Diagnostic Kit for HIV (1/2) Antibody (Colloidal Gold) V2 was granted WHO Prequalification, demonstrating the company's capability to provide reliable diagnostic products. Since then, KHB has forged extensive and diverse partnerships with leading NGOs such as the WHO, Clinton Health Access Initiative, UNICEF, UNFPA, USAID, The Global Fund, PFSCM and IDA Foundation, across multiple countries and regions. KHB's Diagnostic Kit for HIV (1/2) Antibody (Colloidal Gold) V2 is available in several countries and regions, including the US, Switzerland, South Africa, Morocco, and Thailand, with the list continuously expanding.

Early in 2016, KHB's Diagnostic Kit for HIV (1/2) Antibody (Colloidal Gold) V2 was granted WHO Prequalification, demonstrating the company's capability to provide reliable diagnostic products. Since then, KHB has forged extensive and diverse partnerships with leading NGOs such as the WHO, Clinton Health Access Initiative, UNICEF, UNFPA, USAID, The Global Fund, PFSCM and IDA Foundation, across multiple countries and regions. KHB's Diagnostic Kit for HIV (1/2) Antibody (Colloidal Gold) V2 is available in several countries and regions, including the US, Switzerland, South Africa, Morocco, and Thailand, with the list continuously expanding.

KHB's achievement in obtaining EU Class D IVDR Certification is a testament to the company's dedication to delivering advanced and reliable IVD solutions in compliance with the latest safety and regulatory standards. With this milestone, KHB is poised to further enhance its products and services to meet the needs of patients and healthcare providers alike, and to maintain its position as a leading IVD company in China.

About KHB

Shanghai Kehua Bio-engineering Co., Ltd. (KHB, Stock code: 002022.SZ) is an IVD company that boasts a full line of medical diagnostic products, focusing on immune diagnosis, biochemical diagnosis, molecular diagnosis and point-of-care testing (POCT). Since its foundation in 1981, KHB has developed into a high-tech company that integrates R&D, manufacturing and marketing business operations. In 2004, it was listed in the Shenzhen Stock Exchange (SZSE).

For more information, please visit KHB's official website and its LinkedIn, Facebook, and Twitter pages.

For product or corporate information inquiries may be directed to international@skhb.com.

Photo - https://mma.prnewswire.com/media/2244057/20230928111343.jpg

View original content:https://www.prnewswire.co.uk/news-releases/khb-becomes-first-chinese-company-to-obtain-eu-class-d-ivdr-certification-for-its-rapid-test-hiv-colloidal-gold-diagnostic-kit-301953335.html